The following stories appear in full on Today's Vidyya Medical News Service Web site.
Today, the FDA approved a newly formulated version of Tripedia, a diphtheria and tetanus toxoids and acellular pertussis (DtaP) vaccine without preservatives and with only a trace amount of thimerosal.
For more information: Newly Formulated DTaP (Diphtheria, Tetanus, And Pertussis) Vaccine Approved
Thimerosal is very effective in helping to prevent a vaccine from spoiling and inactivating bacteria used to formulate several vaccines, and in preventing bacterial contamination of the final product. Some but not all of the vaccines recommended routinely for children in the United States contain thimerosal. Disease outbreaks have occurred following contamination of multi-dose vaccine vials in the United States and from other countries.
For more information: Questions And Answers: Thimerosal
Among older adults, falls are a serious public health problem. In the United States, one of every three persons over age 65 falls each year and two-thirds of those who fall do so again within six months. Among people age 65 and older, falls are the leading cause of injury deaths and serious injuries. About 9,600 older adults died in 1998 from fall-related injuries. Among seniors with osteoporosis, falls can cause devastating injuries such as hip fractures; 75%–80% of hip fractures are sustained by women. Half of all older
adults hospitalized for hip fracture cannot return home or live independently after their injuries. A comprehensive resource in today's issue will help health professionals get their patients the assistance they need to avoid falls and receive help after falls.
For more information: US Fall Prevention Programs For Seniors: Selected Programs Using Home Assessment And Modification
Women newly diagnosed with HIV have far less virus in their blood than men at the same stage, although the difference disappears later in the course of infection, according to a study from Johns Hopkins University. The study will appear in tomorrow's New England Journal Of Medicine.
For more information: HIV Viral Load Differs By Gender
GlaxoSmithKline and the World Health Organization (WHO) today announce that they have signed an agreement for the development of a new treatment for malaria called LAPDAP.
For more information: GlaxoSmithKline And World Health Organization Sign Agreement To Develop A New Treatment For Malaria
Today's Vidyya articles are:
As always, we hope you enjoy the issue.